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Introduction
Magnetic resonance imaging (MRI) has become a wide-
spread procedure in critical care patients. Some of these
patients are equipped with implanted cardiovascular
diagnostic or therapeutic devices. The main risks during
MRI are movement due to magnetic attraction and
burns. The risks depend on quality and quantity of the
implanted conductive metallic material as well as on the
strength of the magnetic field. There is confusion which
patients with which devices can safely undergo MRI.
This also applies to transpulmonary thermodilution
(TPTD) catheters which currently are not approved to
be left in place during MRI. However, risks of delaying
MRI until the catheter can be removed, potential harms
of removal and risks and costs of repeated arterial can-
nulation have to be outweighed.
Objectives
We analyzed a prospectively maintained TPTD database
for patients undergoing MRI with PiCCO-TPTD (Pul-
siocath; Pulsion Medical Systems SE, Germany) cathe-
ters left in place.
Methods
Patients charts of 16 patients undergoing 20 MRIs with
TPTD-catheters were analyzed for side effects. To detect
potential catheter dysfunction we compared the last mea-
surements before and after MRI (Wilcoxon-test for paired
samples; IBM SPSS 22). Furthermore, a questionnaire
regarding the local standard procedure in case of MRI in
patients with PiCCO-catheter was sent to 11 experts in
hemodynamic monitoring.
Results
20 MRIs in 16 patients (5 male, 11 female); age 63 ±
7 years; APACHE-II ± 5. No local or systemic complica-
tions of the MRI examinations were reported. Hemody-
namic measurements before and after MRI were not
significant different for any parameter derived from
TPTD or pulse contour analysis: CI (4.07 ± 18.35 vs.
4.079 ± 1.41 L/min/²; p = 0.526), GEDVI (775 ± 176 vs.
802 ± 154 ml/m²; p = 0.560), EVLWI (8.7 ± 2.4 vs. 8.9
± 4.1 ml/kg; p = 0.716), SVRI (1513 ± 472 vs. 1456 ±
527 dyn*s*cm-5 *m-2; p = 0.550), SVV (13.8 ± 8.2 vs.
12.6 ± 7.8 %; p = 0.146), dPmax (1392 ± 616 vs. 1423 ±
702 mmHg/s; p = 0.881). Questionnaires: Including our
center, the catheters were removed in five centers in
general and left in situ in six centers. In one center,
strategy has changed to removal despite absence of
evidence for side effects when not removing the cathe-
ter. Seven centers reported on 174 MRI examinations
with the TPTD catheter left in situ without any side
effect or damage to the catheter. Strategies in the
centers removing the catheter comprised delaying the
MRI as well as removal of the catheter before MRI with
and without replacement after MRI.
Conclusions
1.) Despite the limitations of a small number of examina-
tions our data do not give hints for harms to the patients1Klinikum rechts der Isar, II. Medizinische Klinik, Munich, Germany
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or to the TPTD catheter when leaving the TPTD catheter
in situ during MRI.
2.) Limited residual risks of the indwelling catheter have
to be outweighed to the risks of delayed examination or
removal of the catheter and repeated cannulation as well
as to the costs of repeated TPTD-catheter Insertion.
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